Today: 10 June 2026
Beazley share price falls after board rejects Zurich bid — and traders eye the next deadline
22 January 2026
1 min read

Beazley share price falls after board rejects Zurich bid — and traders eye the next deadline

London, Jan 22, 2026, 08:48 GMT — Regular session

  • Beazley shares dipped in early London trading following the insurer’s rejection of Zurich’s most recent cash offer.
  • The board argued that the 1,280p-per-share offer significantly undervalued Beazley and its potential as an independent company.
  • Investors await any updated response from Zurich following the rejection.

Shares of Beazley (BEZ.L) dropped roughly 3% Thursday following the British specialty insurer’s rejection of Zurich Insurance Group’s latest takeover bid. Beazley said the offer undervalued the firm.

This resistance is crucial since the stock has behaved like a deal candidate ever since Zurich’s IPO. Now, the ball is in the bidder’s court. Traders face a familiar UK takeover dilemma: either raise the offer or step aside.

Beazley slipped 3.1% to 1,088 pence by 08:30 GMT, following Wednesday’s close at 1,123 pence. The stock had surged over 40% on Jan. 19 when the bid became public.

Beazley’s board has unanimously turned down Zurich’s latest cash offer of 1,280p per share, following a thorough review with advisers, the company said in a statement. The offer came in lower than Zurich’s previous bid in late June, which valued Beazley at 1,315p per share and roughly 2.4 times tangible book value — a balance-sheet metric excluding intangibles. Beazley highlighted its underwriting performance, noting an average combined ratio of 78% since 2022. (A combined ratio under 100% indicates underwriting profit.)

Zurich’s offer has sparked fresh debate over the value of London-listed specialty insurers in this buyer’s market. Shares of rivals like Hiscox and Lancashire gained Monday, fueled by speculation that more deals could be on the horizon.

Zurich Chief Executive Mario Greco put the ball squarely in the shareholders’ court. “I made an offer, it’s distant from being accepted, and now the shareholders have to speak about it,” he told Insurance Journal in a phone interview. He added, “Beazley is a very complementary business to ours… The fit is very strong.”

The downside is clear. If Zurich fails to boost its offer, the takeover premium on Beazley shares could vanish fast—particularly if risk appetite weakens or insurance pricing shifts unfavorably. A drawn-out public tussle risks diverting management’s focus and increasing scrutiny on short-term underwriting volatility.

The next key deadline comes from the UK takeover timetable: Zurich has until 5 p.m. London time on Feb. 16 to either make a firm offer or withdraw, according to Takeover Code rules.

Stock Market Today

  • Copart (CPRT) Share Price Slump Raises Reassessment Questions Amid Undervaluation
    June 10, 2026, 8:50 AM EDT. Copart's share price has declined 37.7% over the past year, prompting investors to reassess its value. Recent trading closed at $31.31, a 1.5% rise over seven days but down 17.1% year to date. A Discounted Cash Flow (DCF) analysis estimates Copart's intrinsic value at $38.93, suggesting the stock is undervalued by approximately 19.6%. The DCF model, focusing on future free cash flow projections, indicates potential upside if cash flow assumptions hold. Copart trades at a Price-to-Earnings (P/E) ratio of 18.66, reflecting investor expectations on growth and risk. The prolonged multi-year price slump, coupled with evolving market perceptions in vehicle auction and salvage sectors, is driving fresh investor scrutiny on Copart's risk and growth potential.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update
Previous Story

Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update

BT share price jumps as Openreach steps up copper switch-off — UBS still says “sell”
Next Story

BT share price jumps as Openreach steps up copper switch-off — UBS still says “sell”

Go toTop